132 Views
Monday Poster Session
Category: Colorectal Cancer Prevention
Adam Blaisdell, MD, PhD
UCSF
SAN FRANCISCO, CA, United States
n | % Total | % Subgroup | |
Total Patients | 1029 | 100.0 | |
Screen Negative | 802 | 77.9 | |
Known LS | 2 | 0.2 | 0.2 |
Other genetic cancer predisposition syndrome | 3 | 0.3 | 0.4 |
Screen Positive | 227 | 22.1 | |
Known LS | 16 | 1.6 | 7.0 |
Other genetic cancer predisposition syndrome | 16 | 1.6 | 7.0 |
Criteria met: | |||
1+ | 227 | 22.1 | 100.0 |
2+ | 69 | 6.7 | 30.4 |
3+ | 8 | 0.8 | 3.5 |
4+ | 2 | 0.2 | 0.9 |
Prior genetic counseling referral: | |||
Yes | 83 | 36.6 | |
No | 144 | 63.4 | |
Difficulty of Questionnaire | |||
Very easy | 571 | 55.5 | |
Somewhat easy | 301 | 29.3 | |
Neither easy nor hard | 102 | 9.9 | |
Somewhat hard | 40 | 3.9 | |
Very hard | 2 | 0.2 | |
No response | 13 | 1.3 |